Research article
Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement
Arthritis Research & Therapy 2012, 14:R230 doi:10.1186/ar4072
No comments have yet been made on this article.
